Michael McDermott - 25 Feb 2026 Form 4 Insider Report for PFIZER INC (PFE)

Reporting relationship: Executive Vice President
Issuer ticker: PFE
Reported as of: 25 Feb 2026
Net transaction value: +$198,994
SEC form: 4
Accepted by SEC: 27 Feb 2026, 18:34:04 UTC
Prior SEC filing: 06 Mar 2025
Next SEC filing: 05 Mar 2026
Source filing: View source filing
Reporting owner signature: /s/ Shanice A. Reid, by power of atty, for Michael McDermott

Key filing fact

Michael McDermott filed Form 4 for PFIZER INC (PFE) on 27 Feb 2026.

Key facts

This page summarizes Michael McDermott's Form 4 filing for PFIZER INC (PFE).
5 reported transactions and 1 derivative row are listed below.
Accepted by SEC: 27 Feb 2026, 18:34.

Change

Previous filing in this sequence was filed on 06 Mar 2025.
Current net transaction value: +$198,994.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001902464 Primary reporting owner

McDermott Michael

Relationship: Executive Vice President
Address: 66 HUDSON BOULEVARD EAST, ATTN: CORPORATE SECRETARY, NEW YORK
Signature: /s/ Shanice A. Reid, by power of atty, for Michael McDermott
Signature date: 27 Feb 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

PFE transaction

Common Stock

Options Exercise

Transaction value: $1,282,624
Shares: +37,925
Change %: +50%
Price: $33.82
Shares after: 114,534
Date: 25 Feb 2026
Ownership: Direct
Footnotes: F1

PFE transaction

Common Stock

Tax liability

Transaction value: $18,394
Shares: -679
Change %: -0.59%
Price: $27.09
Shares after: 113,855
Date: 25 Feb 2026
Ownership: Direct
Footnotes: F2

PFE transaction

Common Stock

Tax liability

Transaction value: $970,304
Shares: -36,044
Change %: -32%
Price: $26.92
Shares after: 77,811
Date: 25 Feb 2026
Ownership: Direct
Footnotes: F3, F4

PFE transaction

Common Stock

Tax liability

Transaction value: $94,931
Shares: -3,503
Change %: -4.5%
Price: $27.10
Shares after: 74,308
Date: 26 Feb 2026
Ownership: Direct
Footnotes: F5

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

PFE transaction Derivative

Stock Appreciation Rights

Options Exercise

Transaction value: $0
Shares: -37,925
Change %: -100%
Price: $0.000000
Shares after: 0
Date: 25 Feb 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 37,925
Exercise price: $33.82
Footnotes: F6

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 6 footnotes

Footnote F1

The reported transaction constitutes the earn-out of stock appreciation rights (including dividend equivalents thereon).

Footnote F2

The reported transaction constitutes the withholding of shares to satisfy tax obligations in connection with earn-out of stock appreciation rights.

Footnote F3

The reported transaction constitutes the withholding of shares to cover payment of exercise price in connection with earn-out of stock appreciation rights (including dividend equivalents thereon).

Footnote F4

Under the terms of the settlement of the stock appreciation rights the 20-day average of the closing prices of Pfizer common stock ending on the settlement date is used.

Footnote F5

The reported transaction constitutes the withholding of shares to satisfy tax obligations upon the vesting of restricted stock units (including dividend equivalents thereon).

Footnote F6

The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the fifth anniversary of the date of grant.